Recurrent supraventricular tachycardia in a newborn treated with amiodarone: is hyperkalemia the apparent cause?
Supraventricular tachycardia (SVT) is the most common type of arrhythmia observed in children, especially in newborns. Infants with severe SVT must be treated immediately with first-line drugs such as amiodarone. There are some minor and major side effects of amiodarone in this patient group, but no associated electrolyte disorders have been observed. This report describes a newborn whose recurrent SVT attacks during amiodarone treatment were suspected to have been caused by hyperkalemia.
Yildirim
S V
SV
Division of Pediatric Cardiology, Baskent University, Adana Teaching and Medical Research Center, Kurtuluş Mah. 13.sk. Egemert Apt., Kat: 3, Daire No: 7, Adana, Turkey. svefay@yahoo.com
Tiker
F
F
Cengiz
N
N
Kiliçdağ
H
H
D000638:Amiodarone / Q000627:therapeutic use*; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D006801:Humans; D006947:Hyperkalemia / Q000150:complications*; D007231:Infant, Newborn; D008297:Male; D055502:Secondary Prevention; D013617:Tachycardia, Supraventricular / Q000188:drug therapy* / Q000209:etiology
D000889:Anti-Arrhythmia Agents; D000638:Amiodarone